Clinical Trials in Seattle

Showing 7041-7060 of 7,135 trials

Determining the Effect on Patients of Internet-Based Diabetes Disease Management

NCT00220207

This grant supports a 12-month randomized controlled trial comparing usual care versus collaborative disease management over the Internet among disadvantaged African-Americans with Type 2 diabetes. The project aims to: (1) determine the effect of case-managed, Web-based diabetes care on glycemic control, health care utilization, self-efficacy, and patient satisfaction; and (2) qualitatively identify enablers of the successful use of computers, the Internet, and e-Health applications by disadvantaged patients.

Diabetes Mellitus, Type 2

Robert Wood Johnson Foundation63 participantsStarted Sep 2003

Seattle, Washington, United States

UNKNOWNPhase 3< 1 mile

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

NCT00486499

hypothesis: the shorter half-life of Pd-103 versus I-125, will increase the rate of tumor eradication. A total of 660 patients with AJC clinical stage T1c-T2a prostatic carcinoma (Gleason grade 7 to 9 and/or PSA 10-20 ng/ml) will be randomized to implantation with I-125 (144 Gy) versus Pd-103 (124 Gy).

Prostate Cancer

VA Puget Sound Health Care System660 participantsStarted Mar 2003

Seattle, Washington, United States • Seattle, Washington, United States

TERMINATEDPhase 3< 1 mile

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

NCT00243204

This Phase 3 study will compare the efficacy of talabostat plus docetaxel to docetaxel plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based chemotherapy regimen.

Carcinoma, Non-Small Cell Lung

Point Therapeutics400 participantsStarted Jan 2006

Huntsville, Alabama, United States • Muscle Shoals, Alabama, United States • Anchorage, Alaska, United States +93 more locations

Determining the Effect on Patients of Internet-Based Diabetes Disease Management

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Find Trials by Condition in Seattle

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

US Inhaled Insulin Therapeutic Choice Questionnaire Study

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Maintenance Study for Adolescent Depression

Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)